Medical device outsourcing is no longer simply about transferring production to a third-party supplier.
The competitive battle is increasingly centered on who can design, engineer, manufacture, automate, assemble, test, package and scale complex medical technologies.
The company landscape includes global manufacturing giants, highly specialized medical CDMOs, precision component suppliers and companies expanding through acquisitions.
Recent industry analyses consistently identify companies such as Jabil, Flex, Integer Holdings, TE Connectivity, Sanmina, Celestica, Phillips-Medisize, Viant Medical, Nordson, Plexus, West Pharmaceutical Services and Resonetics among the major participants.
Download Sample https://www.precedenceresearch.com/sample/1051
What Types of Companies Are Competing?
| Company Group | Leading Examples | Core Advantage |
|---|---|---|
| Global manufacturing giants | Jabil, Flex, Sanmina, Celestica | Scale and global production |
| Medical-focused CDMOs | Integer, Phillips-Medisize, Viant | Specialized engineering and manufacturing |
| Precision technology specialists | Resonetics, Nordson, Tecomet | Miniaturization and advanced components |
| Connectivity specialists | TE Connectivity | Sensors, connectors and interconnect technologies |
| Drug-device specialists | West Pharmaceutical Services | Injectable and combination products |
| Integrated design-to-production players | Plexus, Viant, Phillips-Medisize | Development through commercialization |
The biggest strategic shift is clear:
Companies are competing to capture a larger portion of the customer’s product lifecycle.
Design → Engineering → Prototype → Validation → Manufacturing → Assembly → Packaging → Lifecycle Support
Why Is Jabil One of the Most Powerful Competitors?
Jabil is one of the largest and most diversified manufacturing partners operating across healthcare and other technology-intensive industries.
Its competitive position is built around:
- Advanced manufacturing
- Electronics integration
- Automation
- Supply-chain management
- Complex assembly
- Product industrialization
- Global manufacturing infrastructure
Jabil’s major advantage is scale combined with technological diversity.
Medical device companies increasingly require expertise beyond traditional mechanical manufacturing. Connected devices, diagnostic systems, wearable technologies and drug-device combination products require electronics, sensors, software integration and automated assembly.
Jabil is expanding deeper into these higher-value activities. Industry reporting in early 2026 also highlighted a partnership with TxSphere aimed at strengthening capabilities for complex drug-device combination products.
Company insight
Jabil’s real competitive advantage is its ability to transfer expertise from electronics and advanced industrial manufacturing into highly regulated healthcare applications.
How Is Flex Using Scale to Strengthen Its Position?
Flex is another major global manufacturing company competing for increasingly complex healthcare programs.
Its capabilities include:
- Product design
- Manufacturing engineering
- Electronics
- Automation
- Supply-chain management
- Digital manufacturing
- High-volume production
Flex is particularly well positioned as healthcare products become more connected and data-driven.
The company’s strategic focus has increasingly included smart manufacturing and AI-enabled production. A 2025 development involving expanded manufacturing analytics capabilities reflects the broader effort to improve production efficiency and data visibility across its operations.
Company insight
Flex benefits from the convergence of healthcare, electronics, automation and connected technology.
What Makes Integer Holdings Different From Larger Manufacturing Giants?
Integer Holdings competes through deep medical specialization.
Its capabilities span areas including:
- Cardiac rhythm management
- Neuromodulation
- Vascular technologies
- Advanced surgical applications
- Portable medical technologies
- Energy systems
- Precision components
- Coatings and specialized processes
Integer has pursued acquisitions to strengthen proprietary and specialized technologies. In January 2025, it completed the acquisition of Precision Coating for approximately US$152 million, adding fluoropolymer and anodic coating capabilities.
Company insight
Integer is not trying to become simply the biggest producer.
Its strategy is to become increasingly difficult to replace.
By adding specialized processes such as precision coatings and advanced component technologies, the company can strengthen customer relationships in applications where supplier qualification and process expertise create higher switching barriers.
Who Is Building the Most Integrated Medical Outsourcing Model?
Phillips-Medisize
Phillips-Medisize has developed a highly integrated approach covering multiple stages of device development and production.
Its capabilities include:
- Product development
- Advanced injection molding
- Electronics
- Automation
- Complex assemblies
- Drug delivery systems
- Diagnostic technologies
- Medical packaging
- Connectivity
- Lifecycle management
The company has reported annual revenue above US$1.6 billion, a workforce of more than 6,500 employees, approximately 30 global locations and multiple innovation centers.
Company insight
Phillips-Medisize is competing to become a long-term product development and manufacturing partner, rather than simply a component supplier.
That model is strategically valuable because winning the development phase can create opportunities to retain production business throughout the product lifecycle.
How Is TE Connectivity Strengthening Its Role?
TE Connectivity occupies a different position from traditional full-service manufacturers.
Its competitive strengths include:
- Sensors
- Connectors
- Interconnect systems
- Miniaturized technologies
- Catheter-related connectivity
- Specialized components
As medical technologies become smaller and more connected, the importance of highly reliable interconnect and sensor technologies increases.
TE Connectivity therefore occupies an important position in the shift toward:
- Wearable devices
- Monitoring systems
- Catheter-based technologies
- Robotic systems
- Connected healthcare equipment
Company insight
TE Connectivity benefits from technological complexity rather than production volume alone.
Why Is Resonetics Becoming More Important?
Resonetics specializes in highly advanced manufacturing technologies.
Its expertise includes:
- Laser processing
- Nitinol processing
- Precision components
- Catheter technologies
- Micro-manufacturing
- Advanced assemblies
In early 2026, Resonetics completed the acquisition of Resolution Medical, expanding its integrated design and manufacturing capabilities in areas including neuromodulation, structural heart and interventional cardiology.
Company insight
Resonetics is expanding from being primarily a specialized technology supplier toward a broader development-and-manufacturing partner.
That evolution reflects a major competitive trend:
Specialists are trying to move upward in the value chain.
Where Does Nordson Create Its Competitive Advantage?
Nordson MEDICAL has historically built strong expertise around precision components and fluid-management technologies.
Its capabilities include:
- Medical tubing
- Catheter components
- Fluid management
- Precision molding
- Specialized assemblies
A notable industry development came in 2025 when Quasar Medical agreed to acquire Nordson Medical’s design and development contract manufacturing businesses in Ireland and Mexico, highlighting the continued restructuring and specialization of the competitive landscape.
Company insight
The Nordson example demonstrates that companies are increasingly refining their portfolios around areas where they have the strongest technological or strategic advantage.
How Is Viant Medical Expanding Its Strategic Value?
Viant Medical focuses heavily on becoming an integrated manufacturing partner for complex medical technologies.
Its service model includes:
- Design and development
- Precision manufacturing
- Automation
- Complex assembly
- Packaging
- Supply-chain support
Viant has also invested in expanding manufacturing capacity for complex and minimally invasive technologies. Its Costa Rica campus expansion increased the site’s footprint to roughly 257,000 square feet, supporting additional production capabilities.
Company insight
Viant’s strategy is centered on capturing the relationship early and scaling with the customer.
What Is Plexus Bringing to the Competitive Landscape?
Plexus combines engineering, manufacturing and supply-chain capabilities.
The company operates across services such as:
- Product development
- New product introduction
- Manufacturing
- Supply-chain management
- Sustaining services
Industry analysis has highlighted its capabilities in digital healthcare, IoMT, robotics, miniaturization and other technology-intensive applications.
Company insight
Plexus is positioned between pure-play medical specialists and global manufacturing giants.
Its value proposition is particularly relevant for companies seeking engineering depth without relying exclusively on the largest contract manufacturers.
Why Are West Pharmaceutical Services and Drug-Device Specialists Gaining Importance?
West Pharmaceutical Services represents another important category: companies specializing in highly regulated drug-delivery and combination technologies.
The company’s focus includes advanced injectable systems and related technologies.
In March 2026, West expanded its Damastown, Dublin facility by 165,000 square feet, with additional automation and high-volume production capabilities targeting injectable drug-delivery applications.
Company insight
The line between pharmaceutical manufacturing and medical device manufacturing is becoming increasingly blurred.
Companies with expertise in drug delivery + devices + automation + regulatory compliance could become strategically more important.
Who Is Competing Through Electronics and System Integration?
Companies such as Sanmina and Celestica bring strong experience in:
- Electronics manufacturing
- System integration
- Complex assemblies
- Supply-chain management
- Advanced manufacturing
Their competitive importance grows as devices incorporate more:
- Sensors
- Connectivity
- Data collection
- Imaging technologies
- AI-enabled systems
- Remote monitoring
Sanmina has also been linked with expansion in cleanroom manufacturing capabilities for connected and wearable device production.
Company insight
The future of outsourcing increasingly belongs to companies that understand both physical devices and electronics.
What Does the Competitive Structure Look Like?
| Company | Main Strength | Strategic Direction |
|---|---|---|
| Jabil | Global scale and advanced manufacturing | End-to-end and complex healthcare production |
| Flex | Electronics and automation | Connected and digitally enabled healthcare |
| Integer Holdings | Specialized medical technologies | High-value components and proprietary processes |
| Phillips-Medisize | Integrated CDMO | Development through commercialization |
| TE Connectivity | Sensors and connectivity | Miniaturized and connected technologies |
| Resonetics | Laser and micro-manufacturing | Moving toward integrated services |
| Viant Medical | Medical-focused production | Complex and minimally invasive devices |
| Plexus | Engineering and manufacturing | Technology-intensive healthcare programs |
| West Pharmaceutical Services | Drug-device systems | Advanced injectable technologies |
| Sanmina | Electronics and system integration | Complex and connected devices |
| Celestica | Advanced manufacturing | Engineering and technology-intensive production |
The competitive landscape remains relatively fragmented, with large-scale companies competing alongside highly specialized technology providers.
How Are Acquisitions Changing the Competitive Battle?
Acquisitions are becoming one of the fastest ways for companies to add specialized capabilities.
Integer Holdings
Acquired Precision Coating for approximately US$152 million in 2025.
Resonetics
Completed the acquisition of Resolution Medical in 2026 to expand integrated development and manufacturing capabilities.
Arterex
Expanded through acquisitions, including Synecco in 2026 and Phoenix S.r.l. in 2025, strengthening European engineering and manufacturing capabilities.
Freudenberg Medical
Expanded precision manufacturing capabilities through the acquisition of Fuji Seiko in 2025, strengthening its position in micro-tubing and hypotube technologies.
The strategy behind these transactions is straightforward:
Buying specialized technology can be faster than building it internally.
What Are OEMs Really Looking for From Outsourcing Partners?
The strongest manufacturing partners are increasingly evaluated across several factors:
Quality
Can the company consistently meet strict regulatory and production requirements?
Engineering
Can it improve product design and manufacturability?
Scale
Can production increase rapidly if demand grows?
Automation
Can it reduce manufacturing complexity and improve consistency?
Geography
Can it offer manufacturing across multiple regions?
Supply-Chain Resilience
Can it reduce dependence on a single country or supplier?
Technology
Can it manufacture increasingly sophisticated devices?
A recent BCG analysis also highlighted the importance of hybrid outsourcing models, estimating that component and sub-assembly activities account for 80%–90% of outsourced medtech activity in the framework it analyzed.
Where Is the Biggest Competitive Opportunity Emerging?
Connected Devices
Jabil, Flex, Sanmina, Celestica and TE Connectivity are well positioned as healthcare products become more digitally connected.
Minimally Invasive Procedures
Resonetics, Viant, Nordson-related businesses and other precision specialists can benefit from increasing device miniaturization.
Drug-Device Combination Products
Jabil, Phillips-Medisize and West Pharmaceutical Services are strengthening capabilities around increasingly sophisticated delivery systems.
Specialized Components
Companies such as Resonetics, Nordson, Spectrum and other component-focused CDMOs occupy important positions because many OEMs continue to use hybrid outsourcing models rather than outsourcing everything to a single provider.
End-to-End Partnerships
The biggest long-term opportunity may belong to companies that can support customers from initial design to global commercial production.
Buy This Report https://www.precedenceresearch.com/checkout/1051
About Us
Healthcare Prism is a dedicated healthcare insights and outreach platform, operating as an extension of Precedence Research. We share relevant perspectives, industry developments, emerging trends, and research-driven insights across the global healthcare sector. Our content is built on the knowledge, research standards, and expertise of Precedence Research, with a focus on making healthcare information clear, accessible, and useful for industry professionals, businesses, researchers, and healthcare stakeholders. Healthcare Prism serves as a focused platform to extend the reach of Precedence Research’s healthcare insights and connect them with a broader professional audience.
You can place an order or ask any questions, please feel free to contact us at [email protected]
Quick Contact:
Europe Region: +44 778 256 0738
North America Region: +1 8044 4193 44
APAC Region: +91 9356 9282 04 and +65 31065601
Visit Our Website: https://www.precedenceresearch.com